Deerfield Management Company
Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NUVL, Brookdale Sr Living, COGT, PRAX, CNC, and represent 38.51% of Deerfield Management Company's stock portfolio.
- Added to shares of these 10 stocks: Brookdale Sr Living (+$428M), CELC (+$98M), Alignment Healthcare (+$93M), LEGN (+$65M), STOK (+$58M), ARWR (+$56M), LNTH (+$55M), ACHC (+$47M), INSP (+$42M), BLTE (+$37M).
- Started 33 new stock positions in KYTX, PHGE, ARVN, TNGX, SDGR, MMS, DOCS, VEEV, RMD, ABEO.
- Reduced shares in these 10 stocks: MRUS (-$287M), Indivior (-$129M), CNC (-$107M), BMY (-$105M), Tandem Diabetes Care (-$87M), , PFE (-$84M), NUVL (-$75M), INSM (-$68M), RVMD (-$60M).
- Sold out of its positions in ADPT, JBIO, ELUT, BAX, TECH, Biomx, BMY, CYH, DHR, XRAY.
- Deerfield Management Company was a net seller of stock by $-169M.
- Deerfield Management Company has $7.8B in assets under management (AUM), dropping by 19.53%.
- Central Index Key (CIK): 0001009258
Tip: Access up to 7 years of quarterly data
Positions held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 150 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 22.2 | $1.7B | -4% | 17M | 100.59 |
|
| Brookdale Sr Living Note 3.500%10/1 (Principal) | 5.5 | $428M | NEW | 307M | 1.39 |
|
| Cogent Biosciences (COGT) | 4.1 | $321M | 9.0M | 35.52 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 3.4 | $266M | +7% | 903k | 294.74 |
|
| Centene Corporation (CNC) | 3.4 | $265M | -28% | 6.4M | 41.15 |
|
| Viatris (VTRS) | 3.2 | $252M | -16% | 20M | 12.45 |
|
| Revolution Medicines (RVMD) | 2.9 | $231M | -20% | 2.9M | 79.65 |
|
| United Therapeutics Corporation (UTHR) | 2.7 | $208M | 426k | 487.25 |
|
|
| Vera Therapeutics Cl A (VERA) | 2.6 | $206M | +11% | 4.1M | 50.64 |
|
| Mirum Pharmaceuticals Note 4.000% 5/0 (Principal) | 2.3 | $181M | 70M | 2.58 |
|
|
| Celcuity (CELC) | 2.2 | $171M | +133% | 1.7M | 99.74 |
|
| Neurocrine Biosciences (NBIX) | 2.1 | $168M | 1.2M | 141.83 |
|
|
| Ionis Pharmaceuticals (IONS) | 2.0 | $157M | 2.0M | 79.11 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.9 | $146M | -2% | 4.2M | 35.08 |
|
| Inspire Med Sys (INSP) | 1.8 | $139M | +43% | 1.5M | 92.23 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.6 | $129M | +100% | 5.9M | 21.74 |
|
| Brookdale Senior Living (BKD) | 1.6 | $126M | 12M | 10.79 |
|
|
| Indivior Ord | 1.6 | $122M | -51% | 3.4M | 35.88 |
|
| Arrowhead Pharmaceuticals (ARWR) | 1.6 | $122M | +84% | 1.8M | 66.39 |
|
| Larimar Therapeutics (LRMR) | 1.5 | $117M | 31M | 3.81 |
|
|
| Catalyst Pharmaceutical Partners (CPRX) | 1.5 | $115M | 4.9M | 23.34 |
|
|
| Adapthealth Corp Common Stock (AHCO) | 1.5 | $114M | 12M | 9.96 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $112M | +17% | 14M | 7.80 |
|
| Ionis Pharmaceuticals Note 1.750% 6/1 (Principal) | 1.2 | $95M | 60M | 1.59 |
|
|
| Alignment Healthcare Note 4.250%11/1 (Principal) | 1.2 | $93M | NEW | 61M | 1.52 |
|
| Silverback Therapeutics (SPRY) | 1.1 | $87M | 7.5M | 11.65 |
|
|
| Pharvaris N V (PHVS) | 1.1 | $87M | +27% | 3.1M | 27.75 |
|
| Savara (SVRA) | 1.0 | $82M | +70% | 14M | 6.03 |
|
| Ideaya Biosciences (IDYA) | 1.0 | $74M | 2.2M | 34.57 |
|
|
| Certara Ord (CERT) | 0.9 | $69M | +15% | 7.8M | 8.81 |
|
| Bio Rad Labs Cl A (BIO) | 0.9 | $69M | 226k | 302.99 |
|
|
| Neogenomics Note 0.250% 1/1 (Principal) | 0.8 | $65M | 73M | 0.89 |
|
|
| Acadia Healthcare (ACHC) | 0.8 | $64M | +280% | 4.5M | 14.19 |
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.8 | $61M | 4.9M | 12.52 |
|
|
| Stoke Therapeutics (STOK) | 0.7 | $58M | NEW | 1.8M | 31.74 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $55M | NEW | 828k | 66.55 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.7 | $53M | +105% | 768k | 69.55 |
|
| Envista Hldgs Corp (NVST) | 0.6 | $50M | 2.3M | 21.71 |
|
|
| Enhabit Ord (EHAB) | 0.6 | $44M | 4.7M | 9.22 |
|
|
| Kymera Therapeutics (KYMR) | 0.6 | $44M | 561k | 77.81 |
|
|
| Caredx (CDNA) | 0.5 | $41M | 2.2M | 18.84 |
|
|
| Disc Medicine (IRON) | 0.5 | $41M | -44% | 511k | 79.41 |
|
| Sionna Therapeutics (SION) | 0.5 | $40M | 971k | 41.14 |
|
|
| Livanova Note 2.500% 3/1 (Principal) | 0.5 | $40M | 34M | 1.16 |
|
|
| Belite Bio Sponsored Ads (BLTE) | 0.5 | $37M | NEW | 234k | 159.96 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $35M | -20% | 3.7M | 9.32 |
|
| Phreesia (PHR) | 0.4 | $34M | +79% | 2.0M | 16.92 |
|
| Embecta Corp Common Stock (EMBC) | 0.4 | $33M | +5% | 2.8M | 11.88 |
|
| Veracyte (VCYT) | 0.4 | $31M | 726k | 42.10 |
|
|
| Moderna Put Option (MRNA) | 0.4 | $30M | 1.0M | 29.49 |
|
|
| Lantheus Hldgs Note 2.625%12/1 (Principal) | 0.4 | $29M | 25M | 1.14 |
|
|
| Beta Bionics (BBNX) | 0.4 | $29M | -19% | 938k | 30.47 |
|
| Ventas (VTR) | 0.3 | $27M | 354k | 77.38 |
|
|
| Immunocore Hldgs Note 2.500% 2/0 (Principal) | 0.3 | $27M | 30M | 0.90 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 0.3 | $27M | 68k | 397.65 |
|
|
| Tango Therapeutics (TNGX) | 0.3 | $26M | NEW | 2.9M | 8.86 |
|
| Xenon Pharmaceuticals (XENE) | 0.3 | $24M | 542k | 44.82 |
|
|
| Spyre Therapeutics Com New (SYRE) | 0.3 | $23M | +15% | 711k | 32.76 |
|
| Foghorn Therapeutics (FHTX) | 0.3 | $20M | +12% | 3.6M | 5.40 |
|
| Compass Therapeutics (CMPX) | 0.2 | $19M | NEW | 3.6M | 5.37 |
|
| Edgewise Therapeutics (EWTX) | 0.2 | $19M | 766k | 24.82 |
|
|
| Kyverna Therapeutics (KYTX) | 0.2 | $19M | NEW | 2.0M | 9.40 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $15M | -49% | 2.7M | 5.50 |
|
| Cormedix Inc cormedix (CRMD) | 0.2 | $13M | -66% | 1.1M | 11.63 |
|
| Oncology Institu (TOI) | 0.2 | $12M | 3.4M | 3.56 |
|
|
| Monopar Therapeutics Com New (MNPR) | 0.1 | $11M | +6% | 171k | 65.30 |
|
| Medline Com Cl A (MDLN) | 0.1 | $11M | NEW | 260k | 42.00 |
|
| Omada Health (OMDA) | 0.1 | $8.7M | 553k | 15.78 |
|
|
| Calcimedica Com New (CALC) | 0.1 | $8.6M | 1.3M | 6.59 |
|
|
| Prestige Brands Holdings (PBH) | 0.1 | $4.3M | +7% | 70k | 61.69 |
|
| Cullinan Oncology (CGEM) | 0.1 | $4.0M | -86% | 386k | 10.35 |
|
| Veeva Sys Cl A Com (VEEV) | 0.1 | $4.0M | NEW | 18k | 223.23 |
|
| RadNet (RDNT) | 0.0 | $3.6M | +25% | 50k | 71.35 |
|
| Labcorp Holdings Com Shs (LH) | 0.0 | $3.5M | +1207% | 14k | 250.88 |
|
| Colfax Corp (ENOV) | 0.0 | $3.4M | +83% | 127k | 26.64 |
|
| Alignment Healthcare (ALHC) | 0.0 | $3.2M | +59% | 164k | 19.75 |
|
| Quest Diagnostics Incorporated (DGX) | 0.0 | $3.2M | NEW | 18k | 173.53 |
|
| Transmedics Group (TMDX) | 0.0 | $3.1M | +99% | 26k | 121.65 |
|
| Insulet Corporation (PODD) | 0.0 | $3.0M | +136% | 11k | 284.24 |
|
| Annexon (ANNX) | 0.0 | $2.9M | 584k | 5.02 |
|
|
| Biolife Solutions Com New (BLFS) | 0.0 | $2.9M | +8% | 120k | 24.18 |
|
| Chemed Corp Com Stk (CHE) | 0.0 | $2.7M | +33% | 6.2k | 427.86 |
|
| Pet Acquisition LLC -Class A (WOOF) | 0.0 | $2.6M | NEW | 936k | 2.81 |
|
| Orthopediatrics Corp. (KIDS) | 0.0 | $2.6M | -25% | 144k | 17.76 |
|
| Cigna Corp (CI) | 0.0 | $2.5M | NEW | 9.2k | 275.23 |
|
| Trupanion (TRUP) | 0.0 | $2.5M | +16% | 66k | 37.37 |
|
| ResMed (RMD) | 0.0 | $2.4M | NEW | 10k | 240.87 |
|
| Boston Scientific Corporation (BSX) | 0.0 | $2.4M | -20% | 25k | 95.35 |
|
| DaVita (DVA) | 0.0 | $2.4M | +12% | 21k | 113.61 |
|
| Doximity Cl A (DOCS) | 0.0 | $2.3M | NEW | 52k | 44.28 |
|
| Dex (DXCM) | 0.0 | $2.2M | +47% | 33k | 66.37 |
|
| Irhythm Technologies (IRTC) | 0.0 | $2.1M | -29% | 12k | 177.44 |
|
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.0 | $2.1M | 93k | 23.00 |
|
|
| CONMED Corporation (CNMD) | 0.0 | $2.1M | -93% | 53k | 40.60 |
|
| Masimo Corporation (MASI) | 0.0 | $2.1M | NEW | 16k | 130.06 |
|
| LeMaitre Vascular (LMAT) | 0.0 | $2.1M | -13% | 26k | 81.10 |
|
| 10x Genomics Cl A Com (TXG) | 0.0 | $2.1M | -51% | 127k | 16.31 |
|
| AtriCure (ATRC) | 0.0 | $2.1M | -40% | 52k | 39.56 |
|
| Halyard Health (AVNS) | 0.0 | $1.9M | +35% | 167k | 11.23 |
|
| CorVel Corporation (CRVL) | 0.0 | $1.9M | -8% | 28k | 67.67 |
|
| Cardinal Health (CAH) | 0.0 | $1.8M | NEW | 9.0k | 205.50 |
|
| Goodrx Hldgs Com Cl A (GDRX) | 0.0 | $1.8M | NEW | 660k | 2.71 |
|
| Surgery Partners (SGRY) | 0.0 | $1.7M | NEW | 113k | 15.45 |
|
| Align Technology (ALGN) | 0.0 | $1.7M | -66% | 11k | 156.15 |
|
| Addus Homecare Corp (ADUS) | 0.0 | $1.7M | NEW | 16k | 107.39 |
|
| Merit Medical Systems (MMSI) | 0.0 | $1.7M | -55% | 19k | 88.14 |
|
| National HealthCare Corporation (NHC) | 0.0 | $1.7M | -17% | 12k | 137.09 |
|
| Alector (ALEC) | 0.0 | $1.6M | 1.1M | 1.56 |
|
|
| Encompass Health Corp (EHC) | 0.0 | $1.6M | NEW | 15k | 106.14 |
|
| Varex Imaging (VREX) | 0.0 | $1.5M | -53% | 132k | 11.65 |
|
| Healthequity (HQY) | 0.0 | $1.5M | +129% | 16k | 91.61 |
|
| Abbott Laboratories (ABT) | 0.0 | $1.4M | NEW | 11k | 125.29 |
|
| Maximus (MMS) | 0.0 | $1.4M | NEW | 17k | 86.32 |
|
| Stryker Corporation (SYK) | 0.0 | $1.2M | +78% | 3.6k | 351.47 |
|
| Alphatec Hldgs Com New (ATEC) | 0.0 | $1.2M | -12% | 57k | 21.04 |
|
| Staar Surgical Com Par $0.01 (STAA) | 0.0 | $1.2M | -46% | 52k | 23.09 |
|
| Edwards Lifesciences (EW) | 0.0 | $1.2M | +115% | 14k | 85.25 |
|
| UFP Technologies (UFPT) | 0.0 | $1.1M | -72% | 5.1k | 222.03 |
|
| Kenvue (KVUE) | 0.0 | $1.1M | -66% | 65k | 17.25 |
|
| MiMedx (MDXG) | 0.0 | $1.1M | +52% | 160k | 6.77 |
|
| Integer Hldgs (ITGR) | 0.0 | $1.0M | +6% | 13k | 78.43 |
|
| PerkinElmer (RVTY) | 0.0 | $999k | -69% | 10k | 96.75 |
|
| Brooks Automation (AZTA) | 0.0 | $859k | -36% | 26k | 33.26 |
|
| Arvinas Ord (ARVN) | 0.0 | $807k | NEW | 68k | 11.86 |
|
| Zoetis Cl A (ZTS) | 0.0 | $717k | -33% | 5.7k | 125.82 |
|
| Cooper Cos (COO) | 0.0 | $638k | -81% | 7.8k | 81.96 |
|
| Schrodinger (SDGR) | 0.0 | $608k | NEW | 34k | 17.88 |
|
| Tandem Diabetes Care Com New (TNDM) | 0.0 | $574k | +113% | 26k | 21.98 |
|
| Rxsight (RXST) | 0.0 | $545k | NEW | 52k | 10.42 |
|
| Integra Lifesciences Hldgs C Com New (IART) | 0.0 | $487k | -95% | 39k | 12.42 |
|
| Abbvie (ABBV) | 0.0 | $460k | NEW | 2.0k | 228.49 |
|
| Harrow Health (HROW) | 0.0 | $426k | NEW | 8.7k | 49.00 |
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $410k | -56% | 52k | 7.85 |
|
| Healthcare Services (HCSG) | 0.0 | $407k | NEW | 21k | 19.12 |
|
| Amphastar Pharmaceuticals (AMPH) | 0.0 | $398k | NEW | 15k | 26.78 |
|
| Repligen Corporation (RGEN) | 0.0 | $360k | -82% | 2.2k | 163.86 |
|
| Steris Shs Usd (STE) | 0.0 | $343k | -47% | 1.4k | 253.52 |
|
| Bellring Brands Common Stock (BRBR) | 0.0 | $321k | -64% | 12k | 26.73 |
|
| Intuitive Surgical Com New (ISRG) | 0.0 | $274k | -91% | 483.00 | 566.36 |
|
| National Vision Hldgs (EYE) | 0.0 | $266k | NEW | 10k | 25.82 |
|
| Biomx Com New (PHGE) | 0.0 | $246k | NEW | 131k | 1.87 |
|
| Humana (HUM) | 0.0 | $235k | 917.00 | 256.13 |
|
|
| Abeona Therapeutics Com New (ABEO) | 0.0 | $211k | NEW | 40k | 5.27 |
|
| The Oncology Institute *w Exp 99/99/999 (TOIIW) | 0.0 | $151k | 1.3M | 0.12 |
|
|
| Quantum Si *w Exp 06/10/202 (QSIAW) | 0.0 | $67k | 333k | 0.20 |
|
|
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $55k | 167k | 0.33 |
|
|
| Butterfly Network *w Exp 02/12/202 | 0.0 | $13k | 733k | 0.02 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $11k | 8.8k | 1.25 |
|
|
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.3k | 167k | 0.02 |
|
|
| Myriad Genetics (MYGN) | 0.0 | $3.1k | 505.00 | 6.15 |
|
Past Filings by Deerfield Management Company
SEC 13F filings are viewable for Deerfield Management Company going back to 2010
- Deerfield Management Company 2025 Q4 filed Feb. 17, 2026
- Deerfield Management Company 2025 Q3 filed Nov. 14, 2025
- Deerfield Management Company 2025 Q2 filed Aug. 14, 2025
- Deerfield Management Company 2025 Q1 filed May 15, 2025
- Deerfield Management Company 2024 Q4 filed Feb. 14, 2025
- Deerfield Management Company 2024 Q3 filed Nov. 14, 2024
- Deerfield Management Company 2024 Q2 filed Aug. 14, 2024
- Deerfield Management Company 2024 Q1 filed May 15, 2024
- Deerfield Management Company 2023 Q4 filed Feb. 14, 2024
- Deerfield Management Company 2023 Q3 filed Nov. 14, 2023
- Deerfield Management Company 2023 Q2 filed Aug. 14, 2023
- Deerfield Management Company 2023 Q1 filed May 15, 2023
- Deerfield Management Company 2022 Q4 filed Feb. 14, 2023
- Deerfield Management Company 2022 Q3 filed Nov. 14, 2022
- Deerfield Management Company 2022 Q2 filed Aug. 15, 2022
- Deerfield Management Company 2022 Q1 filed May 16, 2022